Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
TB-500 (5mg) is a synthetic version of a 43-amino-acid region of thymosin beta-4, a 4.9 kDa protein expressed in nearly all animal cell types
FDA describes BPC-157 as a common name rather than a formal adopted name and notes that different salts and derivatives have been sold under the same label
What if you retested your waterline and failed the Bac-T test a second time
Groups two, three, and four were administered 20, 100, and 500 g/kg BPC157 saline solutions via single IM injections, respectively
In cell culture and in vitro models, BPC-157 has been investigated for its interactions with the nitric oxide (NO) system, including modulation of both eNOS and iNOS pathways
